Safety and efficacy of pralsetinib in patients with advanced RET fusion-positive non-small cell lung cancer: Update from the ARROW trial.

被引：10

作者：

Curigliano, Giuseppe

Gainor, Justin F.

Griesinger, Frank

Thomas, Michael

Subbiah, Vivek

Baik, Christina S.

Tan, Daniel Shao-Weng

Lee, Dae Ho

Misch, Daniel

Garralda, Elena

Kim, Dong-Wan

Paz-Ares, Luis G.

Mazieres, Julien

Liu, Stephen V.

Kalemkerian, Gregory Peter

Houvras, Yariv

Bowles, Daniel W.

Mansfield, Aaron Scott

Zalutskaya, Alena

van der Wekken, Anthonie J.

机构：

[1] IRCCS, European Inst Oncol, Milan, Italy

[2] Univ Milan, Milan, Italy

[3] Massachusetts Gen Hosp, Boston, MA 02114 USA

[4] Carl von Ossietzky Univ Oldenburg, Pius Hosp, Oldenburg, Germany

[5] Heidelberg Univ, Thoraxklin, Thorac Oncol, Heidelberg, Germany

[6] Translat Lung Res Ctr Heidelberg TLRC H, Heidelberg, Germany

[7] German Ctr Lung Res DZL, Heidelberg, Germany

[8] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[9] Univ Washington, Sch Med, Seattle, WA 98195 USA

[10] Natl Canc Ctr Singapore, Singapore, Singapore

[11] Univ Ulsan, Asan Med Ctr, Coll Med, Seoul, South Korea

[12] Helios Clin Emil Behring, Berlin, Germany

[13] Vall Hebron Univ Hosp HUVH, Vall Hebron Inst Oncol VHIO, Med Oncol, Barcelona, Spain

[14] Seoul Natl Univ Hosp, Seoul, South Korea

[15] Hosp Univ 12 Octubre, Madrid, Spain

[16] Inst Univ Canc, Toulouse, France

[17] Georgetown Univ, Sch Med, Dept Hematol & Oncol, Washington, DC USA

[18] Univ Michigan, Ann Arbor, MI 48109 USA

[19] Weill Cornell Med Coll, New York, NY USA

[20] Univ Colorado, Sch Med, Aurora, CO USA

[21] Mayo Clin, Rochester, MN USA

[22] Blueprint Med Corp, Cambridge, MA USA

[23] Univ Groningen, Groningen, Netherlands

[24] Univ Med Ctr Groningen, Groningen, Netherlands

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期

关键词：

D O I：

10.1200/JCO.2021.39.15_suppl.9089

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

9089

引用

页数：3